HLA-identical sibling peripheral blood stem cell transplantation (PBSCT) for hematological malignancies: Limited GVHD and a 69% 4-years DFS after partial in vitro T-cell depletion with CAMPATH-1H in combination with DLI for CML molecular relapses.

被引:0
|
作者
Chalandon, Y
Roosnek, E
Waelchli, L
Helg, C
Chapuis, B
机构
[1] Univ Hosp, Div Hematol, Geneva, Switzerland
[2] Univ Hosp, Div Immunol, Geneva, Switzerland
[3] Univ Hosp, Div Oncol, Geneva, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1692
引用
收藏
页码:464A / 464A
页数:1
相关论文
共 4 条
  • [1] Partial in vitro T-cell depletion with CAMPATH-1H in combination with DLI for CML molecular relapses decreases GVHD with 70% 5-years DFS in HLA-identical sibling PBSC for haematological malignancies
    Chalandon, Y
    Roosnek, E
    Waelchli, L
    Helg, C
    Chapuis, B
    BONE MARROW TRANSPLANTATION, 2004, 33 : S92 - S92
  • [2] Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation
    C Wolschke
    T Zabelina
    F Ayuk
    H Alchalby
    J Berger
    E Klyuchnikov
    U-M Pein
    S Schumacher
    G Amtsfeld
    R Adjallé
    F Wortmann
    H Lellek
    A Randenborgh
    A Zander
    N Kröger
    Bone Marrow Transplantation, 2014, 49 : 126 - 130
  • [3] Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation
    Wolschke, C.
    Zabelina, T.
    Ayuk, F.
    Alchalby, H.
    Berger, J.
    Klyuchnikov, E.
    Pein, U-M
    Schumacher, S.
    Amtsfeld, G.
    Adjalle, R.
    Wortmann, F.
    Lellek, H.
    Randenborgh, A.
    Zander, A.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 (01) : 126 - 130
  • [4] Minimal GvHD after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with Campath-1H
    Von dem Borne, PA
    Beaumont, F
    Starrenburg, I
    Oudshoom, MA
    Hale, G
    Falkenburg, JHF
    Fibbe, WE
    Willemze, R
    Barge, RMY
    BONE MARROW TRANSPLANTATION, 2005, 35 : S149 - S149